Biotricity, Inc. – NASDAQ:BTCY
Founder-led company
Biotricity stock price today
$0.557
+0.29
+110.19%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Biotricity stock price monthly change
-70.06%
month
Biotricity stock price quarterly change
-70.06%
quarter
Biotricity stock price yearly change
-80.66%
year
Biotricity key metrics
Market Cap | 6.83M |
Enterprise value | 39.76M |
P/E | -1.35 |
EV/Sales | 8.77 |
EV/EBITDA | -4.05 |
Price/Sales | 6.02 |
Price/Book | -2.57 |
PEG ratio | 0.01 |
EPS | N/A |
Revenue | 9.99M |
EBITDA | -15.32M |
Income | -21.57M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -227.46% |
Oper. margin | -210.73% |
Gross margin | 60.06% |
EBIT margin | -210.73% |
EBITDA margin | -153.26% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBiotricity stock price history
Biotricity stock forecast
Biotricity financial statements
| Dec 2021 | 1.93M | -7.10M | -368.35% |
|---|---|---|---|
| Mar 2022 | 2.14M | -5.61M | -261.17% |
| Mar 2023 | 2.74M | -4.67M | -170.37% |
| Mar 2024 | 3.17M | -4.18M | -131.59% |
| 2026 | 112.18M | 0 |
|---|
Analysts Price target
Financials & Ratios estimates
| 2023-02-14 | -0.09 | -0.09 |
|---|
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2020 | 3.08% |
|---|---|
| 2021 | 4.02% |
| 2022 | 5.62% |
| 2023 | 23.51% |
| 2024 | 0.14% |
| Sep 2022 | 8053105 | 18.67M | 231.92% |
|---|---|---|---|
| Dec 2022 | 6647096 | 22.12M | 332.91% |
| Mar 2023 | 6510544 | 26.35M | 404.82% |
| Mar 2024 | 5942625 | 35.91M | 604.44% |
| Dec 2021 | -4.48M | 0 | 9.61M |
|---|---|---|---|
| Mar 2022 | -4.75M | -1 | 155.18K |
| Mar 2023 | -1.87M | 0 | 1.99M |
| Mar 2024 | -1.16M | 0 | 1.78M |
Biotricity alternative data
| Aug 2023 | 55 |
|---|---|
| Sep 2023 | 55 |
| Oct 2023 | 55 |
| Nov 2023 | 55 |
| Dec 2023 | 55 |
| Jan 2024 | 55 |
| Feb 2024 | 55 |
| Mar 2024 | 55 |
| Apr 2024 | 55 |
| May 2024 | 55 |
| Jun 2024 | 55 |
| Jul 2024 | 55 |
Biotricity other data
1.72%
-3.54%
of BTCY is owned by hedge funds
844.71K
-1.73M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Sep 2021 | 0 | 41223 |
| Oct 2021 | 0 | 30027 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | ROSA DAVID A director | Common Stock | 3,318 | $3.05 | $10,120 | ||
Sale | ROSA DAVID A director | Common Stock | 9,481 | $3.2 | $30,330 | ||
Sale | ROSA DAVID A director | Common Stock | 17,228 | $3.08 | $53,114 | ||
Sale | ROSA DAVID A director | Common Stock | 34,977 | $3.43 | $119,901 | ||
Sale | ROSA DAVID A director | Common Stock | 6,246 | $3.27 | $20,424 |
| Quarter | Transcript |
|---|---|
| Q4 2024 27 Jun 2024 | Q4 2024 Earnings Call Transcript |
| Q3 2024 21 Feb 2024 | Q3 2024 Earnings Call Transcript |
| Q2 2024 14 Nov 2023 | Q2 2024 Earnings Call Transcript |
| Q1 2024 15 Aug 2023 | Q1 2024 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Dr. Waqaas Al-Siddiq Ph.D. (1985) Founder, Pres, Chief Executive Officer & Chairman | $597,000 |
Mr. S. John Ayanoglou (1966) Chief Financial Officer | $228,000 |
-
What's the price of Biotricity stock today?
One share of Biotricity stock can currently be purchased for approximately $0.56.
-
When is Biotricity's next earnings date?
Unfortunately, Biotricity's (BTCY) next earnings date is currently unknown.
-
Does Biotricity pay dividends?
No, Biotricity does not pay dividends.
-
How much money does Biotricity make?
Biotricity has a market capitalization of 6.83M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 25.15% to 12.06M US dollars. Biotricity made a loss 14.09M US dollars in net income (profit) last year or -$0.09 on an earnings per share basis.
-
What is Biotricity's stock symbol?
Biotricity, Inc. is traded on the NASDAQ under the ticker symbol "BTCY".
-
What is Biotricity's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Biotricity?
Shares of Biotricity can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Biotricity's key executives?
Biotricity's management team includes the following people:
- Dr. Waqaas Al-Siddiq Ph.D. Founder, Pres, Chief Executive Officer & Chairman(age: 40, pay: $597,000)
- Mr. S. John Ayanoglou Chief Financial Officer(age: 59, pay: $228,000)
-
Is Biotricity founder-led company?
Yes, Biotricity is a company led by its founder Dr. Waqaas Al-Siddiq Ph.D..
-
How many employees does Biotricity have?
As Jul 2024, Biotricity employs 55 workers.
-
When Biotricity went public?
Biotricity, Inc. is publicly traded company for more then 7 years since IPO on 16 Feb 2018.
-
What is Biotricity's official website?
The official website for Biotricity is biotricity.com.
-
Where are Biotricity's headquarters?
Biotricity is headquartered at 275 Shoreline Drive, Redwood City, CA.
-
How can i contact Biotricity?
Biotricity's mailing address is 275 Shoreline Drive, Redwood City, CA and company can be reached via phone at +65 08321626.
Biotricity company profile:
Biotricity, Inc.
biotricity.comExchange:
NASDAQ
Full time employees:
55
Industry:
Medical - Devices
Sector:
Healthcare
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
275 Shoreline Drive
Redwood City, CA 94065
Redwood City, CA 94065
CIK: 0001630113
ISIN: US09074H2031
CUSIP: 09074H104
